January 13, 2025
The 2025 Dermatology Summit (an Advancing Innovation in Dermatology conference) took place in San Francisco on January 12, 2025. Dr. Daniel Gil, the Chief Executive Officer of Pelage Pharmaceuticals, was one of the speakers. Dr. Christina Weng, the Chief Medical Officer of Pelage, was also a speaker. I will add more information here if I find it on social media. Note that Pelage is also presenting at the UCLA Ventures Startup Showcase on January 14, 2025.
On a related note, Ostane’s Aesthetics Tech Forum ran from January 9-10 2025 in Newport Beach, California. Among the companies present included Amplifica, Pelage and Eirion Therapeutics.
February 2, 2014
I have covered a number of hair loss and dermatology related organization and conferences on this site in the past. The latest one is Advancing Innovation in Dermatology (AID).
Advancing Innovation in Dermatology
Recently, I came across a new non-profit US-based organization whose leadership team includes several world renowned hair loss research experts. This organization is called Advancing Innovation in Dermatology (AID). Check out their events page for some of their own past events as well as those of other associations. Also check out their Twitter page.
The most well known person on this company’s staff is Ken Washenik of Aderans and Bosley fame. He is perhaps the third most famous hair loss research personality in the world behind George Cotsarelis and Angela Christiano. However, all three of these esteemed scientists have made overly optimistic forecasts about hair cloning or hair multiplication in the past.
However, the person that interests me the most is William Ju, the president of Advancing Innovation in Dermatology. Until mid-2013, he was also president of Follica. While Aderans lost its funding in 2013 and seems to hold limited potential for a rebirth, Follica is still operating successfully.
In fact, just prior to leaving Follica, Dr. Ju was quoted in a Marketwatch article where he seemed to be full of optimism regarding Follica’s potential. So it is surprising that so soon after expressing this optimism, Dr. Ju left Follica and moved to a non-profit organization.